IKZF1 deletions are a significant genetic aberration in ALL, particularly in B-cell precursor ALL (BCP-ALL), where they are associated with poor prognosis and therapy resistance [124]. The gene discussed is IKZF1; the disease is acute lymphoblastic leukemia.